Antibody drug conjugates

The present invention relates to anti-FGFR2 antibodies, antibody fragments, antibody drug conjugates, and their uses for the treatment of cancer.

Saved in:
Bibliographic Details
Main Authors Haubst Nicole, Meyer Matthew John, Batt David Bryant, Petropoulos Konstantin, Hu Tiancen, Toksoz Engin, Jenkins David, Ettenberg Seth Alexander
Format Patent
LanguageEnglish
Published 16.08.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to anti-FGFR2 antibodies, antibody fragments, antibody drug conjugates, and their uses for the treatment of cancer.
Bibliography:Application Number: US201414204023